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. In Brazil, the number of patients with ESRD undergoing renal replacement therapy increased from 42,695 in 2000 to 92,091 in 2010. As many as 90.6% of patients with ESRD receive hemodialysis, and 13.6% of these patients receive non-tunneled catheters 2 . The survival and quality of life of these patients depend on the continued good functioning of dialysis access sites 3 . Bloodstream infection (BSI) is the leading cause of hospitalization and the second most common cause of death among patients receiving regular hemodialysis 4, 5 .
Controlling infection in these patients is a challenge for healthcare staff because hemodialysis is an invasive procedure with an inherent infection risk. Furthermore, catheters are often manipulated during hemodialysis sessions, and patients receiving hemodialysis are immunodefi cient 6 .
Primary BSIs are among the most common nosocomial infections. Data suggest that 60% of hospital-acquired bacteremia cases are associated with the use of central venous catheters (CVCs) 7 . Metastatic sites of infection occur frequently and can include endocarditis, vertebral osteomyelitis, spinal epidural abscess, and septic arthritis 8 . Despite the importance of BSIs, few studies have investigated this issue in patients with ESRD in Brazil. Instead, they have mostly focused on microbiological laboratory surveillance, without association of the results with clinical data 9, 10 . The isolation of the etiologic agent and determination of antimicrobial susceptibility profi le are important for achieving better prognoses. The emergence of multiresistant bacteria is a well-recognized problem. Therefore, surveillance studies are important for the monitoring of the emergence of these microorganisms, especially in immunocompromised patients, such as those undergoing hemodialysis.
METHODS

RESULTS
The purpose of this study was to describe BSI in patients with ESRD using CVCs, describe the patients' characteristics, identify the etiologic agents, and analyze the catheter-related variables considered as risk factors for BSI.
Study design
This paper reports on a prospective cohort study of 59 patients with ESRD receiving hemodialysis by means of a CVC at a Brazilian tertiary care teaching hospital in the State of Mato Grosso do Sul from April 2010 to December 2011. The principal outcome investigated was BSI.
Data collection and BSI surveillance
Included in the study were patients with ESRD using catheters and recently admitted to the hospital's hemodialysis ward, patients undergoing hemodialysis who lost an arteriovenous fi stula (AVF) or a catheter, and patients with implanted tunneled or non-tunneled catheters. The sample included both ESRD inpatients and outpatients. All subjects included in the study were adults and agreed to participate. Individuals in intensivecare units and children were excluded.
Patients were followed up until four months postcatheterization. All CVCs were inserted using aseptic techniques according to the protocol recommended by the Hospital Infection Control Committee.
Data were collected during the hemodialysis sessions. We collected at least two peripheral blood samples from all patients who had signs and symptoms of BSI. Blood was collected in compliance with the criteria of the National Agency of Sanitary Surveillance
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. The catheter insertion sites were inspected, and blood and/or catheter-tip cultures were monitored. Nursing staff trained in hemodialysis changed the dressings and manipulated the catheters using rigorous aseptic techniques. At the end of each hemodialysis session, the catheter lumens were aseptically locked with heparin. The catheters were not fi lled with any other thrombolytic agent or antimicrobial solution, and the connectors were not part of a closed access system.
For every patient, we checked for the presence of hyperemia at the catheter site, exudation upon catheter insertion, and symptoms such as fever, shivering, and chills during each hemodialysis session. Demographic, clinical, and laboratory data were collected from medical records and from the hospital's laboratory database.
Empirical systemic antibiotic therapy was initiated whenever the patients developed fever or shivering. Vancomycin and ceftazidime were the fi rst choices for the initiated antibiotic regimen. The regimen was adjusted, if necessary, once the results of blood culture tests became available. The catheter was removed if fever or shivering symptoms persisted for more than 48h. In cases suggestive of BSI, according to medical criteria, the catheter tip was removed and subjected to culture. One week after antibiotic therapy initiation, new blood cultures were collected.
Microbiological tests
Blood cultures were performed in the hospital's microbiology laboratory. The laboratory used a Bactec automated system (Becton Dickinson, Sparks, USA) for blood culture tests and a Vitek2 Compact automated system (BioMérieux, Durham, NC, USA) for the identifi cation of pathogens and antimicrobial susceptibility profi ling of blood samples. In cases of blood cultures with the same microorganism for one month or consecutive months, only one agent was considered.
Defi nitions
Bacteremia and candidemia were defi ned as clinical signs or symptoms of infection along with at least two blood cultures that tested positive for bacteria or yeasts of the genus Candida
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. Diagnosis of CVC-related BSI was defi ned as at least one blood culture and catheter tip culture with the same agent, with clinical manifestations of infection and no other apparent source of infection 13 .
Bacteria were considered multidrug-resistant when exhibiting resistance to different classes of antimicrobial medications 7 .
Hypoalbuminemia was defi ned as serum albumin levels of less than 3.5g/dL 4 .
Statistical analysis
To investigate the possible associations between the study variables, chi-square tests, chi-square tests for trends, and Fisher's exact test were applied, and the relative risks were calculated with 95% confidence intervals. Cox regression analysis was used to estimate the adjusted relative risks using variables with signifi cance levels lower than 20% and those of clinical and epidemiological relevance. BioEstat 5.0 (Sociedade Mamirauá, Belém, Brazil) and Epi Info (version 3.5.3) were used for the statistical analyses 14, 15 . Statistical signifi cance was defi ned as p ≤ 0.05.
Ethical considerations
Our study was approved by the Research Ethics Committee of the Federal University of Mato Grosso do Sul (permit 1687/2010). All individuals who agreed to participate in the study signed informed consent forms stating that they were freely participating.
Of the 59 patients with ESRD using CVCs for hemodialysis, 30 (50.8%) developed bacteremia, 7 (11.6%) had mixed bacteremia and fungemia, and 22 (37.3%) had no evidence of BSI. The overall infection rate was 62.8% (95% CI, 50.4-75.1%).
The only patient who used a tunneled catheter developed BSI. Among the other 58 patients who used non-tunneled catheters, bloodstream infection developed in 62%.
Of the patient group, 54.2% were female and 44% were older than 60 years. All patients were adults, and their ages ranged from 23-85 years (median, 58 years). The inpatients comprised 96.7% of the study population. Twelve (20%) patients died during the study period.
The demographic and clinical characteristics of the patients are shown in Table 1 . Bivariate analysis indicated that the BSI frequency was 1.7 times higher in patients with hypoalbuminemia (76.5%) compared with patients with normal albumin levels. The main signs and symptoms observed in patients with BSI were chills, 35 (94.6%); shivering, 34 (91.9%); and hyperemia at the time of CVC insertion, 24 (64.9%).
In total, 114 CVCs were inserted during the study period, and 111 (97.4%) of these were non-tunneled devices. The catheters were inserted into the right jugular vein in 45% of the catheterizations. None of the variables related to CVC use were associated with the development of BSI ( Table 2) .
With regard to changes in or evolution of vascular access, 31 patients were switched from non-tunneled to arteriovenous catheters, and 16 patients progressed to tunneled catheters.
Thirty-seven patients developed BSI, and 19 (50%) of these patients were catheterized because they lacked an AVF that could be used. In the other patients (50%), the need for urgent hemodialysis required catheterization.
Multivariate analysis revealed no association between BSI in hemodialysis patients and the following variables: hypoalbuminemia (p = 0.220; 95% CI 0.75 < RR < 3.44), gender (p = 0.368; 95% CI 0.69 < RR < 2.69), indication for catheterization (loss, maturation, or awaiting AVF) (p = 0.670; 95% CI 0.58 < RR < 2.35), number of catheter sites (p = 0.690; 95% CI 0.54 < RR < 2.54), length of catheterization (days) (p = 0.701; 95% CI 0.99 < RR < 1.01), and number of hemodialysis sessions (p = 0.924; 95% CI 0.96 <RR < 1.04). Table 3 lists the microorganisms isolated from blood and catheter-tip cultures. Of the 124 blood cultures, 65 (52.4%) tested positive. Gram-positive cocci (n = 18; 27.7%) were the most common microorganism observed, and Staphylococcus aureus accounted for most of the gram-positive infections. Among the Gram-negative bacteria isolated (n = 28; 43.1%), Stenotrophomonas maltophilia was the most prevalent. Six Candida species were isolated, the most prevalent of which were Candida parapsilosis complex species.
In 10 patients, the same type of microorganism was isolated from the blood and catheter-tip cultures. Among these cultures, the most frequently isolated pathogens were S. aureus (6) and the Burkholderia cepacia complex (4). There was no signifi cant difference between the prior use of antibiotics and multidrug resistance of microorganisms (p = 0.751; RR = 0.80; 95% CI, 0.26 to 2.48).
Of the 15 S. aureus isolates observed in the blood and catheter-tip cultures, only one was resistant to methicillin. Seven out of nine coagulase-negative Staphylococcus (CNS) isolates were resistant to this antibiotic. All S. epidermidis (n = 7) isolates were resistant to methicillin. Of the 14 enterobacteria isolated, none produced beta-lactamase, and one isolate of Enterobacter cloacae was resistant to ertapenem. One of the two Pseudomonas aeruginosa isolates was resistant to ceftazidime, cefepime, imipenem, meropenem, ciprofl oxacin, and piperacillin-tazobactam. Acinetobacter baumannii (3) and Chryseobacterium indologenes (5) were among the most resistant Gram-negative bacteria.
DISCUSSION
The prevention and control of bacterial and fungal infections in patients with ESRD receiving hemodialysis via CVCs is a constant concern for health professionals. Although CVCs are an important component in the management of patients with ESRD, these catheters also signifi cantly contribute to BSIs 10 .
In the present study, most patients were older than 58 years, a fi nding that corroborates those of Sesso et al. 2 A previous study 16 conducted in a teaching hospital in Campo Grande indicated that most patients admitted to medical wards with CVC-related complications were older than 60 years. Patients with advanced age tend to be immunologically impaired, and they often have co-existing chronic diseases, such as systemic hypertension and diabetes. We also observed co-existing chronic disease in our patients, and our fi ndings corroborate those of other researchers 17 . To our knowledge, this is the fi rst study in central-western Brazil to describe BSIs in patients with ESRD receiving hemodialysis. The prevalence of BSIs in our group of patients was much higher (62.8%) than that among patients attending a hemodialysis center in Pakistan (25%) 18 .
A study by Brito et al. 19 on nosocomial infection in the neonatal intensive care unit of the Uberlândia University Hospital, in Brazil, demonstrated that BSI was the main cause of nosocomial infection (69.3%) and indicated that CVC use was an independent risk factor (p < 0.05) for nosocomial infection. Even though previous studies 9, 18 reported that prolonged use of CVCs increases the risk of BSI, we observed no evidence to support this claim. In the present study, no association was observed between the long-term use of CVCs and the increased occurrence of BSI. This fi nding is possibly related to the small number of patients evaluated, methodological difficulties inherent in prospective studies, and specifi c features of the cohort (type of patients and restricted sample group).
Bivariate analysis revealed that hypoalbuminemia was a signifi cant risk factor for BSI in our patient group. It is well known that hypoalbuminemia is associated with disease severity. Lukowsky et al. 4 observed that during the first 90 days of hemodialysis, one-third of all patient deaths were associated with albumin levels of less than 3.5g/dL. Thus, the identifi cation and treatment of hypoalbuminemia may decrease the risk of infection.
Our results indicated a higher incidence of chills and shivering in patients who developed BSI, which was expected because these symptoms were criteria for blood culture collection. Hyperemia at the site of catheter insertion was suggestive of BSI (p < 0.05), corroborating the results of a previous study 20 .
In the present investigation, non-tunneled catheters were the most frequently used catheters. Our results suggest that these catheters should be avoided in patients with ESRD due to the associated high risk of infection. We recommend that temporary catheters be replaced as soon as possible with AVFs or arteriovenous grafts. A tunneled CVC should be implanted if this is not possible 18, 21 .
In our study, the right jugular vein was the most common access route for CVC. This fi nding is similar to the fi ndings of Jones et al. 22 The jugular vein is the preferred access point for CVCs, as subclavian vein stenosis can be avoided and because the site allows for future preparation of AVFs 21 . Nevertheless, Grothe et al. 23 reported that patients receiving hemodialysis who had CVCs inserted in the jugular vein were 56% more likely to develop BSI than those who had catheters implanted in the subclavian vein.
We also observed that a large percentage of our patients (n = 35; 59.3%) began hemodialysis due to an emergency situation and therefore required CVCs. This fi nding is similar to the results of other studies 24, 25 . We believe that these emergency cases were related to delayed diagnosis of ESRD.
Although blood culture tests are considered the gold standard in the diagnosis of bacteremia and fungemia, previous studies reported variable sensitivity of these tests in detecting these infections and low sensitivity in identifying patients treated with antimicrobials 11, 26 . The high (52.4%) percentage of positive blood cultures in our study may be a result of the nature of the population investigated. Patients receiving hemodialysis are most often individuals who present with concomitant chronic illnesses, and they are prone to immunodefi ciency.
Similar to the fi ndings of Bevilacqua et al. 27 , we observed that Gram-negative bacteria were predominant among the isolates. The infections caused by non-fermenting Gram-negative bacilli, such as Acinetobacter baumannii, Pseudomonas aeruginosa, Chryseobacterium indologenes, and Stenotrophomonas maltophilia, are difficult to treat because they are highly resistant, can cause outbreaks of nosocomial infection, and are often associated with high mortality rates 28, 29 .
In this study, Staphylococcus aureus was the most frequent pathogen observed in blood cultures. Classically, these pathogens are often associated with BSIs because they are part of the skin microbiota. To date, numerous reports have indicated that BSIs associated with Staphylococcus aureus are serious and can result in severe metastatic infections such as sepsis, endocarditis, and endophthalmitis 30, 31 .
BSIs caused by S. aureus require aggressive treatment, including catheter removal. In addition, if the infection does not resolve within 72h 30 , transesophageal echocardiography should be performed to rule out other potential sources of infection.
The emergence of multidrug-resistant gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), coagulase-negative Staphylococcus (MRSCN), and vancomycin-resistant Enterococcus spp. (VRE), complicates the management of infections caused by these agents 32 .
The isolation of Kocuria kristinae in the catheter-tip cultures is a rare fi nding. Dunn et al. 33 , previously described a case of severe intravascular infection complicated by septic pulmonary embolus and thrombosis in a patient with hyperemesis gravidarum as a result of this pathogen and the use of parenteral nutrition by a CVC.
Candida yeasts, which are recognized as opportunistic pathogens, gain access to the bloodstream due to skin breakdown and are predominantly found in immunodefi cient patients 34 . Non-albicans Candida species, such as Candida parapsilosis, have emerged as important infectious agents 35 . This pathogen can secrete glycosylated proteins that form biofi lms in solution and adhere to plastic materials such as intravascular catheters 36 . Brito et al. 37 reported that Candida parapsilosis candidemia is associated with neutropenia, the use of CVCs, and chemotherapy.
Two patients had positive blood cultures for Candida guilliermondii for long periods, namely 6 and 12 months.
Because of the clinical condition of these patients and the diffi culty of establishing new venous access, nephrologists chose not to remove the catheters. Based on a previous study 35 , C. guilliermondii can be considered an emerging candidemia pathogen in central-western Brazil.
We propose that in a hemodialysis unit a multidisciplinary team should conduct surveillance studies to detect BSIs. To this end, the necessary measures to prevent bacteremia and other complications associated with infection in patients with ESRD can be instituted in a timely manner. Since our study was conducted, one of the measures instituted to reduce the rate of BSI in patients with ESRD is the use of connectors in closed access systems and the exchange of these connectors every seven days. Other measures should also be implemented, such as the training of multidisciplinary teams to specifi cally take care of CVCs in patients with ESRD. The use of antibiotic seals and thrombolytic agents is also recommended.
In conclusion, it is important to identify which pathogens cause BSIs among patients in hemodialysis units because this information will guide initial therapy 27 . Surveillance studies by multidisciplinary teams are necessary so that appropriate measures can be implemented to prevent bacteremia and other complications associated with infection in patients with ESRD. We observed a high prevalence of Gram-negative, bacteriarelated BSIs among our patients with ESRD who received hemodialysis via a CVC.
